Drug Topics

JANUARY 29, 2025

Scott Nelson, PharmD, MS, FAMIA, ACHIP, discussed the increasingly crucial role artificial intelligence has played in streamlining pharmacy services.

315

315

STAT

JANUARY 29, 2025

Curie.Bio, the biotech accelerator and investment firm started by Alexis Borisy and Zach Weinberg, has raised another $340 million to invest in startups. Borisy and Weinberg’s firm was created to upend the biotech financing model , offering both capital and expert assistance to founders seeking on option outside of traditional VC funding. The idea has resonated with venture capitalists — several of whom have invested in Curie.Bio — and startups.

116

116

Drug Topics

JANUARY 29, 2025

A recent systematic review and meta-analysis found that almost half of all patients with type 2 diabetes were deficient in multiple micronutrients.

247

247

PharmaVoice

JANUARY 29, 2025

Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 29, 2025

Natalie DiPietro Mager, PharmD, PhD, discusses the role of community pharmacy in maternal health.

Community Pharmacies 247

Community Pharmacies 247

PharmaVoice

JANUARY 29, 2025

Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer alternatives to expand the pain management landscape.

FDA 147

FDA 147

Pharmafile

JANUARY 29, 2025

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has announced positive results for the phase 2a study into BPL-003 in patients with moderate-to-severe Alcohol Use Disorder (AUD). The study, labelled NCT05674929, was conducted at Kings College London and Clerkenwell Health, both UK.

Labelling 64

Labelling 64

European Pharmaceutical Review

JANUARY 29, 2025

Researchers have developed and optimised a novel sensing strategy for isomer discrimination by combining advanced spectroscopy with machine learning. The approach is based on surface-enhanced Raman scattering (SERS) substrates (ie, plasmonic platforms). Montes-Garca et al. explained that they fabricated advanced SERS substrates made of quasi-spherical gold nanoparticles (Au NPs) synthesised via a seeded growth method.

59

59

Pharmafile

JANUARY 29, 2025

Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence (NICE) for AGAMREE (vamorolone) to be used as treatment of Duchenne Muscular Dystrophy (DMD) in patients who are aged 4 or older in the UK. The guidance follows the approval of vamorolone from the Medicines and products Regulatory Agency (MHRA) […] The post NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera appeared first on Pharmafil

FDA 59

FDA 59

Pharmacy Times

JANUARY 29, 2025

Kathy Campbell, PharmD, shares her experiences helping 4 generations of patients.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 29, 2025

Follow along today for ongoing coverage of Robert F Kennedy Jr.'s first Senate confirmation hearing, where he will take questions from Democratic and Republican lawmakers. | Robert F. Kennedy Jr. is taking questions from the Senate Finance Committee, hoping to earn confirmation as HHS Secretary.

116

116

Pharmacy Times

JANUARY 29, 2025

Through similar targeting of the RdRp enzyme, these treatments could offer groundbreaking new options for patients with COVID-19 if proven effective in real-world trials.

120

120

STAT

JANUARY 29, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news.

111

111

Pharmacy Times

JANUARY 29, 2025

Isatuximab is a CD38-targeting monoclonal antibody that has demonstrated significant clinical success in improving minimal residual disease rates and progression-free survival.

110

110

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 29, 2025

Montefiore Health System is partnering with Amazon One Medical to open up access to primary and specialty care in New Yorks Westchester County and surrounding areas.

107

107

Pharmacy Times

JANUARY 29, 2025

The authors note that transferrin saturation levels may be a modifiable risk factor of chronic kidney disease (CKD) progression and all-cause mortality.

103

103

pharmaphorum

JANUARY 29, 2025

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics

FDA 94

FDA 94

Pharmacy Times

JANUARY 29, 2025

This marks the first US biologic license application filing acceptance for a biosimilar candidate to golimumab.

FDA 97

FDA 97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 29, 2025

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment

90

90

Pharmacy Times

JANUARY 29, 2025

Preliminary phase 1 trial results demonstrate that patients with small cell lung cancer generated early clinical activity after being administered ZL-1310.

FDA 95

FDA 95

Fierce Healthcare

JANUARY 29, 2025

Abridge launched a new generative AI product for emergency care and its currently in use at several health systems, including Deaconess Health System, Emory Healthcare, Johns Hopkins Medicine and UChicago Medicine.

84

84

Pharmacy Times

JANUARY 29, 2025

MB-105 is a first-in-class CD5-targeted chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed or refractory CD5-positive T-cell lymphoma.

FDA 82

FDA 82

Fierce Healthcare

JANUARY 29, 2025

Using personalized data and predictive algorithms, the platform generates a custom care plan, which can be analyzed against personal financial data, insurance coverage and healthcare trends to preserve family savings throughout the care journey.

Insurance Coverage 81

Insurance Coverage Insurance 81

Pharmacy Times

JANUARY 29, 2025

Data indicates fedratinibs role as an effective second-line treatment in patients with myelofibrosis who have been previously treated with a JAK inhibitor, such as ruxolitinib, though more research is necessary.

73

73

Fierce Healthcare

JANUARY 29, 2025

Systole exclusively provides virtual group care to women with heart disease. In its six-week, hour-long sessions, patients receive information on heart disease, get care from a cardiologist and support each others' journeys through the disease.

77

77

Pharmaceutical Technology

JANUARY 29, 2025

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the pharmaceutical industry.

72

72

Fierce Healthcare

JANUARY 29, 2025

While major payers skipped out on this years event, health tech companies, health systems and insurtechs all made appearances to share their latest updates with investors.

77

77

Pharmacy Times

JANUARY 29, 2025

Pharmacists can have informed discussions with patients about the importance of adherence to tuberculosis (TB) treatment regimens, especially for patients with active TB.

69

69

Fierce Healthcare

JANUARY 29, 2025

Plans available through Healthcare.gov denied an average of 20% of claims in 2023, according to a new analysis from KFF.

69

69

pharmaphorum

JANUARY 29, 2025

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

66

66

Fierce Healthcare

JANUARY 29, 2025

The academic health systems' vision, NC Children's, will be a private nonprofit entity featuring a 500-bed hospital, an outpatient care center and a behavioral health center.

Hospitals 65

Hospitals 65

Pharmacy Times

JANUARY 29, 2025

The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.

65

65

pharmaphorum

JANUARY 29, 2025

Discover why live marketing is the future, and why it matters now more than ever. Explore the latest trends, strategies, and tips for successful live marketing campaigns.

64

64